Sorry, you need to enable JavaScript to visit this website.

CAMPTOSAR® (irinotecan HCl) Indications and Usage

1 INDICATIONS AND USAGE

  • CAMPTOSAR is indicated as a component of first-line therapy in combination with 5-fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic carcinoma of the colon or rectum.
  • CAMPTOSAR is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.

What's New

No Current Announcements.

Search

Please enter your search term(s) for CAMPTOSAR®